Short Anterograde Refractory Period Research Articles

Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation.

Atrial fibrillation (AF) with fast ventricular response over an overt accessory pathway (AP) (preexcited AF) with a short anterograde refractory period is a potentially malignant arrhythmia. This study aimed to evaluate the safety and efficacy of amiodarone for preexcited AF management. This study enrolled 103 patients with evidence of AP in electrocardiography. Patients with preexcited AF were included in the study. Intravenous amiodarone (300 mg) was infused for 30 min for all patients in the AF rhythm. Electrophysiological parameters were evaluated before amiodarone injection and 2 h after pharmacological or electrical cardioversion. Antegrade and retrograde refractory periods of the atrioventricular node (AVN) and AP, as well as antegrade and retrograde Wenckebach points of AVN, were increased significantly after amiodarone infusion. Furthermore, the mean of the shortest preexcited RR interval was increased during the monitoring period. Comparing the preexcited index at the beginning of the study and before cardioversion (2 h later) revealed that the QRS complexes changed to a wider pattern as the preexcitation index changed from 80.61 to 92.26 (P < 0.001). Nineteen (18.4%) patients converted to the sinus rhythm with amiodarone infusion. No ventricular arrhythmia was detected during monitoring. Amiodarone could be considered a safe drug in patients with preexcited AF for rate control despite its relatively low efficacy in conversion to the sinus rhythm.

Clinical and Demographic Characteristics of WPW Syndrome Attending Arrhythmia Clinic of NICVD

Wolff-Parkinson-White syndrome is a disorder characterized by presence of an accessory pathway which predisposes patients to tachyarrhythmias and sudden death. Among patients with WPW syndrome, atrioventricular reentrant tachycardia (AVRT) is the most common arrhythmia, accounting for 95% of re-entrant tachycardias. It has been estimated that one-third of patients with WPW syndrome have atrial fibrillation (AF). AF is a potentially life-threatening arrhythmia. If an accessory pathway has a short anterograde refractory period, then rapid repetitive conduction to the ventricles during AF can result in a rapid ventricular response with subsequent degeneration to ventricular fibrillation (VF). The study population included a total of 255 patients in whom 175 (68.62%) were men and 80 (31.38%) were women. Demographic data and clinical characteristics are depicted in Table 1. Left and right WPW syndrome were existing in 70.59% and 29.41% of patients respectively. Documented narrow QRS SVT was present in 96.86%, broad QRS SVT was in 2.75% and AF was in 3.14% of patients. Antiarrhythmic drugs most frequently used were Digitalis, Metoprolol, Sotalol, Amiodarone and Verapamil DOI: http://dx.doi.org/10.3329/bmj.v41i2.18809 Bangladesh Medical Journal 2012 Vol. 41 No. 2: 50-53

Sudden Death and Ventricular Preexcitation: Is it Necessary to Treat the Asymptomatic Patients?

Currently, asymptomatic ventricular preexcitation, which has been put at rest for many decades, remains a clinical challenge as there are no predictors of sudden death, which can be the first clinical presentation of the syndrome. Identification of risk factors for sudden death is important, considering the availability of a definitive treatment. Now, as radiofrequency catheter ablation of accessory pathways has reported success rates approaching 100 percent without major complications in many centers worldwide, it becomes unacceptable that even one asymptomatic individual with WPW will die or will experience life-threatening arrhythmic events. In our extensive experience a short anterograde refractory period of accessory pathways, inducibility of sustained tachyarrhythmias and the presence of multiple accessory pathways are the strongest predictors of life-threatening arrhythmias and sudden death. Therefore, it is not yet justified that, after an incidental diagnosis of WPW syndrome has been made, no risk stratification by invasive testing is done. Subjects at high risk, particularly if young or adolescent, should be identified and then ablated in the same session as they can develop lethal arrhythmic events within a few years and this is our current practice. Recently, we sent a questionnaire to investigate clinical practices over a large number of centers around the world about asymptomatic ventricular preexcitation. A total of 100 replies were received and the results demonstrate that there is worldwide agreement in performing invasive electrophysiologic testing and prophylactic ablation in selected subjects. These findings provide strong evidence to revisit current guidelines, which appropriately in the absence of evidence had been conservative.

FBI (Fast Broad Irregular)

HomeCirculationVol. 114, No. 24FBI (Fast Broad Irregular) Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBFBI (Fast Broad Irregular)A Case for the Secret Service? Sergio Richter, MD and Pedro Brugada, MD, PhD Sergio RichterSergio Richter From the Heart Rhythm Management Institute, Department of Cardiology, Free University of Brussels, Brussels, Belgium. Search for more papers by this author and Pedro BrugadaPedro Brugada From the Heart Rhythm Management Institute, Department of Cardiology, Free University of Brussels, Brussels, Belgium. Search for more papers by this author Originally published12 Dec 2006https://doi.org/10.1161/CIRCULATIONAHA.106.641746Circulation. 2006;114:e638–e639A 34-year-old man without a medical history of cardiac disease presented to our emergency room with fast and irregular palpitations. An instantaneously recorded surface ECG revealed the diagnosis (Figure). The tracing showed an irregular, wide QRS-complex tachycardia with right bundle-branch block, right superior axis deviation, and short RR intervals varying from 160 to 340 ms. The widths of the right bundle-branch block–shaped QRS complexes varied in response to changes in ventricular cycle length. A narrow QRS complex with normal axis was observed (Figure, asterisk), indicating a normally conducted capture beat. Download figureDownload PowerPointTwelve-lead ECG during fast, broad, and irregular (FBI) tachycardia. Preexcited atrial fibrillation with rapid anterograde conduction over a left posterolateral bypass tract is present. Note the normal, narrow QRS complex (asterisk) among the irregularly irregular preexcited ventricular complexes and the varying degrees of preexcitation depending on variation in ventricular cycle length (the concertina phenomenon). The shortest RR interval is 160 ms.This grossly irregular, rapid right bundle-branch block tachycardia represented preexcited atrial fibrillation (AF) with anterograde conduction over a left posterolateral accessory pathway, leading to irregularly irregular preexcited ventricular complexes with varying degrees of preexcitation. The shortest RR interval during preexcited AF was 160 ms, indicating a short anterograde refractory period of the accessory pathway and an increased risk for the development of ventricular fibrillation and sudden death.The differential diagnosis of preexcited AF includes ventricular tachycardia and atrial fibrillation with aberrancy. The presence of an apparent fusion and capture beat could lead one to the diagnosis of ventricular tachycardia, because these findings are considered diagnostic for ventricular tachycardia. Morphologically speaking, the tachycardia is ventricular in origin. Nevertheless, the marked cycle-length variation of more than 100% strongly argues against ventricular tachycardia and instead favors preexcited AF as the underlying arrhythmia mechanism. The right superior axis deviation and the fact that longer RR intervals lead to more fully preexcited QRS complexes compared with shorter RR cycles (the concertina phenomenon) virtually exclude AF with solely aberrant conduction.Preexcited atrial fibrillation with rapid ventricular response reveals a typical electrocardiographic pattern that is often diagnostic at first glance. Because of its characteristic ECG features (fast, broad, and irregular), this tachyarrhythmia has been named FBI tachycardia. This potentially life-threatening clinical condition is obviously a case for the emergency rather than the secret service.DisclosuresNone.FootnotesCorrespondence to Sergio Richter, MD, Heart Rhythm Management Institute, Department of Cardiology, Free University of Brussels, Laarbeeklaan 101, 1090 Brussels, Belgium. E-mail [email protected] Previous Back to top Next FiguresReferencesRelatedDetailsCited By Littmann L, Olson E and Gibbs M (2019) Initial evaluation and management of wide-complex tachycardia: A simplified and practical approach, The American Journal of Emergency Medicine, 10.1016/j.ajem.2019.04.027, Online publication date: 1-Apr-2019. December 12, 2006Vol 114, Issue 24 Advertisement Article InformationMetrics https://doi.org/10.1161/CIRCULATIONAHA.106.641746PMID: 17159067 Originally publishedDecember 12, 2006 PDF download Advertisement SubjectsArrhythmiasElectrophysiology

When to Perform Catheter Ablation in Asymptomatic Patients With a Wolff-Parkinson-White Electrocardiogram

What to do when a person without any cardiac complaint shows a Wolff-Parkinson-White (WPW) pattern on the ECG has been an important question for more than 2 decades. Recent articles by Pappone et al1–3 make it necessary to revisit that question. Epidemiological data indicate that 0.1% to 0.3% of the general population have ECG findings suggesting that during sinus rhythm, in addition to AV conduction over the AV node His pathway, there is also AV conduction over an accessory AV pathway (AP).4 This means that each year ≈4 new cases are found in a population of 100 000. It is also known that there is a 4-fold increase of this finding in family members of WPW patients.5 The WPW patient is often symptomatic because of cardiac arrhythmias. When arrhythmias are present, the disorder is called the WPW syndrome. The 2 most common types of arrhythmia in the WPW syndrome are (1) a circus movement tachycardia (CMT), also called an AV reentrant tachycardia, in which AV conduction goes by way of the normal AV conduction system and VA conduction over the AP and (2) atrial fibrillation (AF).6 AF can be a life-threatening arrhythmia in the WPW syndrome if the AV AP has a short anterograde refractory period (RP), allowing many atrial impulses to be conducted to the ventricle. That will result in very high ventricular rates with possible deterioration into ventricular fibrillation (VF) and sudden death.7,8 A CMT that in general is well tolerated by the patient when additional heart disease is absent may deteriorate into AF, and the ventricular rate and risk for VF will depend on the anterograde RP of the AP. Therefore, the most important question in the asymptomatic WPW patient in whom the typical ECG accidentally is recorded is whether he or …

The asymptomatic patient with the Wolff-Parkinson-White electrocardiogram.

Sudden death can be the first manifestation of the Wolff-Parkinson-White (WPW) syndrome. The underlying mechanism being atrial fibrillation with a very high ventricular rate, because of a short anterograde refractory period of the accessory atrioventricular pathway (AP), deteriorating into ventricular fibrillation. Information on the anterograde refractory period of the AP is therefore important to recognize asymptomatic people with the WPW ECG at risk for dying suddenly. Several noninvasive tests are available to identify the low risk patient. Decision making when to interrupt the AP in asymptomatic WPW patients not at low risk requires an invasive study to document the electrophysiological properties of the AP and to determine its exact location.

Deceptive surgical results in three siblings with familial Wolff-Parkinson-White syndrome

Three siblings with familial Wolff-Parkinson-White syndrome and two instances of sudden death are described. In all of them, multiple accessory pathways with a very short anterograde refractory period and rapid ventricular responses during atrial fibrillation had been documented, thus surgical ablation of the bypass tracts had been performed. Although abolition of the accessory pathway conduction had been demonstrated post-operatively, an electrophysiologic evaluation performed after 2-8 years showed resumption of conduction over the anomalous connections, with life-threatening arrhythmias during induced fast atrial rhythms. This report demonstrates that apparent success of surgery for pre-excitation syndrome, judged during the postoperative course, may be illusory in some patients, and return of accessory pathway conduction can occur later on.

Flecainide and encainide.

Flecainide and encainide (class IC) are presently under clinical evaluation in Italy. They prolong the duration of the QRS but not the period of ventricular repolarisation: the prolongation of QT is due solely to the prolongation of the Q-J. Flecainide and encainide are extremely powerful and are suitable for the treatment of reciprocating supraventricular paroxysmal tachycardia and of persistent reciprocating tachycardia, the prophylaxis of WPW atrial fibrillation including cases with a short anterograde refractory period of the anomalous pathway and the treatment of ventricular ectopic beats and ventricular tachycardia. Both drugs are probably effective for the treatment of atrial fibrillation. However, in the case of atrial flutter they are of little effect of sinus rhythm cardioversion; on the other hand they significantly prolong the duration of the A-A interval, with variable results on ventricular rate. Flecainide and encainide have 'parodoxical' arrhythmogenic effects, related to administration dosages, severity of the arrhythmia and seriousness of cardiopathy. Encainide shows peculiar pharmacokinetics due to hepatic oxidating metabolisation and to production of metabolites; among these the O-demethylencainide and the 3-methoxy-O-demethylencainide have an antiarrhythmic activity, which is probably more important than the encainide parent and is longer-lasting. There are 'extensive', 'poor' and 'non-metaboliser' subjects. This results in wide pharmacokinetic inter- and intraindividual variability which must be taken into account during clinical treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Supraventricular arrhythmias in children

Sudden death may occur in children with supraventricular arrhythmias. Sick sinus syndrome, particularly if associated with tachycardia, may result in sudden death in children who have had open heart surgery and rarely in children with a normal heart. Children with supraventricular tachycardia rarely die. Only those with junctional automatic tachycardia or Wolff-Parkinson-White syndrome have died. Patients with a short anterograde refractory period may be at risk of sudden death. Surgical division of the accessory connection can prevent sudden death. Digitalis may accelerate atrioventricular (AV) conduction in patients with Wolff-Parkinson-White syndrome and, thus, should be used only after testing in the electrophysiology laboratory. Sudden death due to complete AV block should be preventable using pacemakers. Neonates with a ventricular rate less than 55 beats/min or children with a rate less than 45 beats/min should receive pacemaker therapy because of the statistical probability of death or syncope. Ventricular ectopic beats, particularly if frequent or multiform, may be an indication for pacemaker insertion. Patients with surgical complete AV block that persists for more than 7 to 10 days should receive physiologic pacemakers for the prevention of sudden death and hemodynamic benefit.

Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome

In Wolff-Parkinson-White (WPW) syndrome, the two most commonly occurring arrhythmias are circus movement tachycardia (CMT) and atrial fibrillation (AF). In 70% of patients with clinically documented CMT in whom the arrhythmia could be initiated by programmed electrical stimulation of the heart, the same CMT could still be initiated after long-term oral amiodarone administration. Spontaneous clinical recurrence of the arrhythmia was, however, observed in only 10% of patients. This finding suggests that the beneficial effect of amiodarone on CMT is primarily based on the prevention of the CMT-initiating premature beat. This may also apply to atrioventricular nodal reentrant tachycardia, in which amiodarone is also extremely effective in preventing relapses. The role of amiodarone in other forms of reentrant, or ectopic, supraventricular tachycardias is less well defined. During AF in WPW syndrome, the ventricular rate is related to the duration of the anterograde refractory period of the accessory pathway. Amiodarone prolongs this value, resulting in the reduction of ventricular rate during AF. Unfortunately, in the presence of a short anterograde refractory period of the accessory pathway, amiodarone results in only a small amount of lengthening of this value. In these patients the beneficial effect of amiodarone may primarily be related to the prevention of episodes of AF. We also found that the effect of oral amiodarone on the duration of the anterograde refractory period of the accessory pathway can (1) be abolished by sympathetic stimulation with isoproterenol and (2) be predicted from the effect of ajmaline or procainamide given intravenously. These observations clearly have practical clinical implications.